The University of Texas Health Science Center, Houston
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center, Houston sits in the top decile of US sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center, Houston: 732 sponsored US clinical trials, 144 recruiting.
The University of Texas Health Science Center, Houston sponsors 732 registered US clinical trials on ClinicalTrials.gov, 144 of them currently recruiting, and 436 completed. 98 of these trials are in Phase 3-4 (later-stage) and 139 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 8 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center, Houston ranks in the top decile of sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
436 of 521 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
732 total, page 6 of 15
The Feasibility, Usability, and Acceptability of Using the Oculus™ Virtual Reality Gaming Technology in Stroke Survivors for Upper Extremity and Cognitive Rehabilitation
NCT05672628
Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder (Pilot Study)
NCT05631548
CompARing Long terM Outcomes in Chronic Stroke Survivors Across Investigational Assessments Following a Prescribed Upper Extremity Exercise Program
NCT05659875
Exploring the Perspectives and Experiences of PrEP-eligible Black Women in Texas in Relation to Readiness for PrEP Uptake and Adherence
NCT05530993
Effects of Radiofrequency Ablation of Posterior Nasal Nerves on Inflammatory Cytokines, Peak Nasal Inspiratory Flow, and Nasal Blood Flow in Patients With Chronic Rhinitis
NCT05648565
A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder
NCT05844930
Effect of Nasal Positive Airway Pressure Versus Standard Care on Oxygenation and Ventilation During Propofol-based Sedation for Colonoscopy in Patients With High Risk of Airway Obstruction
NCT05524220
Aromatherapy Protocol for Pain Reduction in Hospice Patients
NCT05617144
Exenatide for Smoking Cessation and Prevention of Weight Gain
NCT05610800
Feasibility of Mindfulness Meditation Training and Home Practice in Persons With Spinal Cord Injury
NCT05556057
Patient-centered Outcomes After Permanent Female Sterilization Procedure(POPS Trial)
NCT05518175
SmokefreeSGM, A Text-based Smoking Cessation Feasibility Trial for Sexual and Gender Minority Groups
NCT05645354
Nurturing Healthy Teachers
NCT05542537
Brighter Bites & UT Physicians Produce Rx Program
NCT05556070
Protocolized Initiation of Clonidine to Prevent Dexmedetomidine Withdrawal
NCT05575219
Permissive Intrapartum Glucose Control
NCT05553275
Me & You-Tech: A Socio-Ecological Solution to Teen Dating Violence for the Digital Age
NCT05225727
Positive Parenting: Empowering Young Mothers Experiencing Homelessness With a History of Inter-personal Violence to Improve Parenting Strategies
NCT05139251
The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy
NCT05480111
Facilitating Learning Health Care (LHC) and Neonatal Research: Effects of a Brief Introductory Discussion Between a Neonatologist and the Parents of Eligible Infants
NCT05541536
Safe Babies: Parenting Action Plan ( PAP )
NCT05467371
Intubation Conditions Achieved With Rapid Co-administration of Rocuronium and Propofol Versus Classical Induction
NCT05509192
Implant Primary Stability and Ridge Dimensional Changes Utilizing the Osseodensification Protocol
NCT05283928
Comparing Tissue Adhesives in Port Site Closure
NCT05492721
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
NCT05479123
Evaluation of the SHARE! Peer Toolkit Training
NCT05382416
Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery
NCT05129514
Effects of Pioglitazone on Stress Reactivity and Alcohol Craving
NCT05107765
Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease
NCT05200585
Self-management EdUcation and SuPport to Promote PsychOsocial Health Among StRoke Survivors and Informal Caregivers in a VirTual Stroke Community (SUPPORT)
NCT05487144
Clinical and Microbiologic Outcomes of Adjunctive Antimicrobial Photodynamic Therapy in the Non-surgical and Surgical Treatment of Teeth With Periodontal Disease
NCT05252000
Examining the Feasibility and Acceptability of a Tailored Version of a Mindfulness-Based Intervention (MBI) Among Youth Experiencing Homelessness (YEH)
NCT04950816
Vale+ Tu Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19
NCT05248399
Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy
NCT05244525
Lifestyle Improvement for Teens With Bariatric Surgery
NCT05393570
CATCH Healthy Smiles:An Elementary School Oral Health Intervention Trial
NCT04632667
Does BMI Influence Pain Follow vNOTE Surgery
NCT05230407
Nourishing the Community Through Culinary Medicine
NCT05624775
SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups
NCT05029362
Comparison of Low and High Tidal Volumes in Acute Spinal Cord Injury
NCT04912583
Aerosolized Endotracheal Lidocaine to Avoid Intracranial Pressure Spikes in Patients With Severe Traumatic Brain Injury
NCT05058677
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
NCT05049616
Using Social Media to Decrease Healthcare Utilization for Pediatric Asthma
NCT05013788
Effects of Photobiomodulation on Postoperative Pain After Primary Endodontic Therapy in Molars With Symptomatic Apical Periodontitis
NCT05032612
High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster Headache
NCT04570475
Suvorexant to Reduce Symptoms of Nicotine Use
NCT04234997
Home-based tDCS for Apathy in Alzheimer's Disease
NCT04855643
Safety Monitoring for a Novel 3D Printed Mandibular Advancement Device
NCT05018234
Comparison of Effectiveness of Mask Ventilation and Endotracheal Tube in Pharynx (TTIP) in Patients With Potential Difficult Airway
NCT05005390
Evaluation of Aerosol in a Dental Clinic
NCT04659928
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 55 |
| Phase 2 | 84 |
| Phase 3 | 13 |
| Phase 4 | 85 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center, Houston pipeline
144 recruiting of 732 indexed (20% open); 436 completed (60%).
Phase mix: 98 late (III/IV) vs 139 early (I/II) (balanced across stages).
Top condition: Stroke (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center, Houston: open-pipeline peers nationwide
Peers matched on 732 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center, Houston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 732 trials (± recruiting share)
- University of Miami · 721 trials · 20% recruiting
- Sanofi · 713 trials · 10% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- University of Chicago · 20% recruiting · 796 trials
Related
What to do with this The University of Texas Health Science Center, Houston page
732 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center, Houston or any single study.
- 144 of The University of Texas Health Science Center, Houston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition The University of Texas Health Science Center, Houston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center, Houston pipeline card: 732 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.